Phadia AB Announces FDA Clearance of ImmunoCAP Rapid
Phadia announces the recent FDA clearance of ImmunoCAP Rapid, the first point-of-care test to assist in the diagnosis of allergy in the physicians office.
Read MorePhadia announces the recent FDA clearance of ImmunoCAP Rapid, the first point-of-care test to assist in the diagnosis of allergy in the physicians office.
Read MorePresident Barack Obama set up an executive office for healthcare reform at the White House on Wednesday, saying the overhaul was one of the biggest priorities for the first year of his presidency.
Read MoreGen-Probe announced today that the Company has completed its acquisition of Tepnel Life Sciences plc for approximately $136.4 million.
Read MoreThere is still plenty of unmet need in US laboratories for new molecular testing equipment, according to a new Kalorama Information market research report based on a 2008 survey of 1000 interviews with laboratories.
Read MoreBeckman Coulter Inc has expanded its drugs of abuse test menu to include a DRI* Oxycodone Enzyme Immunoassay (OXYX). The assay is for the qualitative and semi-quantitative determination of oxycodone and its metabolite, oxymorphone, in human urine.
Read More